The Food and Drug Administration issued an emergency use authorization for Novavax’s COVID-19 vaccine on Wednesday. The two-shot vaccine was authorized for use in people 18 years and older. FDA Commissioner Dr. Robert M. Califf said in a statement: “Authorizing an additional COVID-19 vaccine expands the available vaccine options for the prevention of COVID-19, including …
Continue reading “FDA authorizes emergency use of Novavax COVID-19 vaccine”